Literature DB >> 27146433

Enhanced thrombopoietin but not G-CSF receptor stimulation induces self-renewing hematopoietic stem cell divisions in vivo.

Larisa V Kovtonyuk1, Markus G Manz1, Hitoshi Takizawa2.   

Abstract

In steady-state adult hematopoiesis, most hematopoietic stem cells (HSCs) are in the resting phase of the cell cycle. Upon enhanced hematopoietic demand, HSCs can be induced to divide and self-renew or differentiate. However, the cell-extrinsic signals inducing HSC cycling remain to be elucidated. Using in vivo high-resolution single HSC divisional tracking, we directly demonstrate that clinically applied thrombopoietin receptor but not granulocyte colony-stimulating factor (G-CSF) receptor agonists drive HSCs into self-renewing divisions leading to quantitative expansion of functional HSC as defined by their in vivo serial multilineage and long-term repopulating potential. These results suggest that thrombopoietin mimetics might be applicable to expand HSCs in vivo and to sensitize thrombopoietin receptor-expressing HSCs to cell cycle-dependent cytotoxic agents.
© 2016 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27146433     DOI: 10.1182/blood-2015-09-669929

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Sleepwalking stem cells.

Authors:  Jeffrey A Magee
Journal:  Blood       Date:  2017-04-06       Impact factor: 22.113

2.  Granulocyte colony-stimulating factor mobilizes dormant hematopoietic stem cells without proliferation in mice.

Authors:  Jeffrey M Bernitz; Michael G Daniel; Yesai S Fstkchyan; Kateri Moore
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

Review 3.  Inflammatory signals in HSPC development and homeostasis: Too much of a good thing?

Authors:  Tiago C Luis; Cedric S Tremblay; Markus G Manz; Trista E North; Katherine Y King; Grant A Challen
Journal:  Exp Hematol       Date:  2016-07-15       Impact factor: 3.084

4.  Integrin αvβ3 enhances the suppressive effect of interferon-γ on hematopoietic stem cells.

Authors:  Terumasa Umemoto; Yu Matsuzaki; Yoshiko Shiratsuchi; Michihiro Hashimoto; Takayuki Yoshimoto; Ayako Nakamura-Ishizu; Brian Petrich; Masayuki Yamato; Toshio Suda
Journal:  EMBO J       Date:  2017-07-03       Impact factor: 11.598

Review 5.  Inflamm-Aging of Hematopoiesis, Hematopoietic Stem Cells, and the Bone Marrow Microenvironment.

Authors:  Larisa V Kovtonyuk; Kristin Fritsch; Xiaomin Feng; Markus G Manz; Hitoshi Takizawa
Journal:  Front Immunol       Date:  2016-11-14       Impact factor: 7.561

6.  Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient.

Authors:  Akira Sakamaki; Takayuki Watanabe; Satoshi Abe; Kenya Kamimura; Atsunori Tsuchiya; Masaaki Takamura; Hirokazu Kawai; Satoshi Yamagiwa; Shuji Terai
Journal:  Clin J Gastroenterol       Date:  2017-03-21

7.  The transcription factor Zfp90 regulates the self-renewal and differentiation of hematopoietic stem cells.

Authors:  Ting Liu; Wei-Xia Kong; Xiao-Yi Tang; Man Xu; Qing-Han Wang; Bin Zhang; Liang-Ding Hu; Hu Chen
Journal:  Cell Death Dis       Date:  2018-06-07       Impact factor: 8.469

Review 8.  Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection.

Authors:  Eric M Pietras; Markus G Manz; Francisco Caiado
Journal:  J Exp Med       Date:  2021-06-15       Impact factor: 14.307

9.  Clonal dominance and transplantation dynamics in hematopoietic stem cell compartments.

Authors:  Peter Ashcroft; Markus G Manz; Sebastian Bonhoeffer
Journal:  PLoS Comput Biol       Date:  2017-10-09       Impact factor: 4.475

10.  Thrombopoietin protects hematopoietic stem cells from retrotransposon-mediated damage by promoting an antiviral response.

Authors:  Daniela Barbieri; Emilie Elvira-Matelot; Yanis Pelinski; Laetitia Genève; Bérengère de Laval; Gayathri Yogarajah; Christian Pecquet; Stefan N Constantinescu; Françoise Porteu
Journal:  J Exp Med       Date:  2018-04-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.